Clinisol 39 mg/100mL 39 mg/100 mL Injection, solution

Clinisol 39 mg/100mL is an intravenous solution containing essential amino acids for nutritional support. This product, manufactured by Baxter Healthcare Corporation, is designed to provide vital nutrients for patients requiring parenteral nutrition. Ideal for those needing amino acid supplementation, Clinisol supports overall health and recovery.

Clinisol 39 mg/100mL is used to provide essential amino acids to patients who cannot obtain adequate nutrition through oral intake. This intravenous solution is often utilized in clinical settings to support nutritional needs, particularly for those undergoing medical treatments that affect nutrient absorption. The amino acids in Clinisol help maintain muscle mass and overall health, making it a crucial component in parenteral nutrition regimens.

When administered intravenously, Clinisol 39 mg/100mL delivers essential amino acids directly into the bloodstream. These amino acids are vital for various bodily functions, including muscle repair and overall metabolic health. Patients may experience improved nutritional status and better recovery outcomes when using this solution as part of their treatment plan.

Clinisol 39 mg/100mL should be administered under the supervision of a healthcare professional. It is important to follow proper handling and storage guidelines to ensure the solution remains effective and safe for use. Patients with known allergies to any of the amino acids in the solution should avoid using Clinisol. Always consult with a healthcare provider before starting any new nutritional regimen.

Clinisol 39 mg/100mL may interact with other medications or supplements, particularly those that affect nutrient absorption or metabolism. It is important to inform your healthcare provider about all medications and supplements you are taking before starting Clinisol. Additionally, certain medical conditions may require dosage adjustments or special monitoring when using this solution.